This guideline compiles up-to-date legal requirements across all U.S. states and territories, clarifying when healthcare providers and laboratories must report negative Hepatitis C test outcomes. It offers a clear, state-by-state breakdown to help public health entities and providers comply with surveillance obligations and improve data completeness.
This guideline presents a comprehensive state-by-state legal analysis of obligations for healthcare providers and laboratories to report negative HIV test outcomes. It clearly highlights jurisdictional differences, helping public health officials and clinicians ensure compliance with surveillance mandates and improve disease tracking.
This video provides a clear, detailed demonstration of the steps involved in administering and reading the Mantoux tuberculin skin test.
This webpage provides clinical guidance on the diagnosis and treatment of tuberculosis (TB) and latent TB infection (LTBI) in Wisconsin, outlining risk assessment, symptom evaluation, testing methods, and treatment protocols. It includes links to CDC resources and encourages use of state and national tools to support accurate diagnosis and effective care.
This journal discusses the integration of hepatitis C management into primary care as a key strategy for eliminating the disease. It examines barriers to care, the role of direct-acting antivirals, and the importance of screening and treatment within primary care settings.
This journal examines the clinical course of autoimmune hepatitis (AIH) in Hispanic and African American patients at a South Bronx hospital. The findings contribute to a better understanding of AIH in diverse racial and ethnic groups, emphasizing the need for tailored healthcare strategies.
This journal compares the effectiveness of Heplisav-B and standard hepatitis B vaccines as boosters for healthcare workers with low immunity to hepatitis B, measured by anti-HBs antibody levels. Results show that Heplisav-B offers a significantly higher seropositivity rate (99.4%) compared to the standard vaccine (92.7%).
This webpage discusses the impact of incorrect penicillin allergy labels on treatment delays for syphilis patients. It highlights how mislabeling a patient as allergic to penicillin can result in suboptimal treatments and prolonged infections.
This guideline outlines the Doxy-PEP Protocol for the prevention of certain sexually transmitted infections (STIs), specifically targeting syphilis, gonorrhea, and chlamydia, following potential exposure. It provides guidelines for healthcare providers on how to administer doxycycline as post-exposure prophylaxis (PEP), detailing protocols for prescription, timing, and patient education to reduce the risk of infection.
